Clinical Psychopharmacology

Clinical Psychopharmacology

Pharmacological Treatment is the main stay of therapy for many mental health conditions. The optimal use of various agents to treat, maintain, and prevent deterioration is a key to better outcome. We have focused on studying relapse in first episode psychosis. We have also set up programs to investigate treatment related side effects and lack of response, in the hope of exploring innovative treatment strategies. Innovative adjunct therapy with a traditional chinese herbal extracts (ginsenosides) have been explored to enhance cognitive function in chronic patients. Use of Traditional Chinese Medicine to address hyperprolactinaemia is being carried out in collaboration with the School of Chinese Medicine.

Current/Developing projects:
  • Treatment resistance
    We collaborated with Prof Honer in carried out a classic study on the use of risperidone augmentation to clozapine in the treatment of clozapine resistant patients. Further studies are under way to explore neurobiological mechanisms of development of treatment resistant schizophrenia-spectrum disorders.
Dr. Sherry KW Chan (Lead)
Prof. Eric YH Chen
Dr. WC Chang
Dr. Edwin HM Lee
Dr. Christy LM Hui
Dr. WC Chan